Spark Therapeutics (ONCE) Misses Q1 EPS by 11c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Spark Therapeutics Reports First Quarter 2016 Financial Results and Recent Business Highlights
May 4, 2016 7:29 AM EDTCompany makes progress across multiple programs
Appoints Daniel R. Faga as Chief Business Officer
PHILADELPHIA, May 04, 2016 (GLOBE NEWSWIRE) -- Spark Therapeutics (NASDAQ: ONCE) today announced financial results for the quarter ended March 31, 2016 and updated investors on its progress.
During the last few months we have continued to make progress across our portfolio of gene therapy candidates targeting the eye, liver and the central nervous system, said Jeffrey D. Marrazzo, co-founder and chief executive officer... More
Spark Therapeutics Announces Multiple Presentations at Upcoming Investor Meetings
May 3, 2016 5:15 PM EDTPHILADELPHIA, May 03, 2016 (GLOBE NEWSWIRE) -- Spark Therapeutics (NASDAQ: ONCE) today announced that members of its management team will participate in three upcoming conferences in May:
Deutsche Bank 41st Annual Healthcare Conference on Wednesday, May 4, 2016, at 8:00 a.m. at The InterContinental, Boston  Piper Jaffray GenomeRX Symposium on Tuesday, May 17, 2016, at The... More